Cytosorbents (CTSO)
(Delayed Data from NSDQ)
$0.83 USD
0.00 (-0.38%)
Updated May 14, 2024 04:00 PM ET
After-Market: $0.84 +0.01 (1.01%) 6:18 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/6/24 |
---|---|
Current Quarter | -0.09 |
EPS Last Quarter | -0.12 |
Last EPS Surprise | 0.00% |
ABR | 1.67 |
Earnings ESP
|
-3.85% |
---|---|
Current Year | -0.34 |
Next Year | -0.17 |
EPS (TTM) | -0.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.85M | 10.06M | 40.30M | 47.75M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 10.34M | 10.48M | 41.33M | 49.76M |
Low Estimate | 9.40M | 9.70M | 39.51M | 44.10M |
Year ago Sales | 9.42M | 8.81M | 36.35M | 40.30M |
Year over Year Growth Est. | 4.60% | 14.19% | 10.88% | 18.48% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.09 | -0.08 | -0.34 | -0.17 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.10 | -0.08 | -0.34 | -0.09 |
High Estimate | -0.07 | -0.07 | -0.31 | -0.09 |
Low Estimate | -0.10 | -0.08 | -0.36 | -0.26 |
Year ago EPS | -0.14 | -0.21 | -0.64 | -0.34 |
Year over Year Growth Est. | 35.71% | 61.90% | 46.88% | 49.02% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.09 | -0.08 | -0.34 | -0.17 |
7 Days Ago | -0.10 | -0.08 | -0.36 | -0.17 |
30 Days Ago | -0.10 | -0.08 | -0.36 | -0.17 |
60 Days Ago | -0.11 | -0.09 | -0.48 | -0.21 |
90 Days Ago | -0.11 | -0.09 | -0.48 | -0.21 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.09 | -0.08 | -0.36 | -0.17 |
Zacks Consensus Estimate | -0.09 | -0.08 | -0.34 | -0.17 |
Earnings ESP | -3.85% | -4.35% | -6.93% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.12 | -0.12 | -0.21 | -0.14 | NA |
Estimate | -0.12 | -0.14 | -0.12 | -0.11 | NA |
Difference | 0.00 | 0.02 | -0.09 | -0.03 | -0.03 |
Surprise | 0.00% | 14.29% | -75.00% | -27.27% | -22.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more